Flavia Matovu
@fmatovu2
Followers
94
Following
226
Media
13
Statuses
139
Joined June 2014
Captured in the moment! This photo was taken at a PURPOSE 1 MU-JHU Mityana team building event celebrating @GileadSciences' groundbreaking results on a twice-yearly PrEP injection. It's fascinating how the photo ended up on the Gilead booth at IAS 2025 in Rwanda. Truly humbled!
0
0
2
RT @mujhu_care_ltd: In the next 30 minutes, Our Director of Research, Dr. Flavia Kiweewa Matovu joins a @newvisionwire X space with HIV adv….
0
2
0
RT @mujhu_care_ltd: MU-JHU is honored to be represented by Dr. Flavia Matovu Kiweewa at TECA 2025, the Triple Elimination Conference. She….
0
2
0
RT @gad_rogers: . @UNYPA1 and @HS_InsightUg are hosting a X-Space on "HIV & Tech: Can Digital Innovations Power a More Sustainable Respons….
0
7
0
I recently had the utmost honor of talking to the president of Uganda about @GileadSciences' twice-yearly injection, Lenacapavir that offered 100% protection against HIV acquisition among young women in Uganda and South Africa. #LongactingPrEP #AccessForAll
0
1
4
RT @tvwestUG: #WestUpdates | KAMPALA. Wiiki y’omwaka ogu eya Makerere University kworeka ebibacondorize n’ebi babaasize kuhangahangaho yata….
0
2
0
RT @ntvuganda: The #AIDSSymposiumUg is underway at the Sheraton Hotel, focusing on Uganda's progress in the fight against HIV/AIDS and stra….
0
3
0
RT @ntvuganda: HIV is heterogeneous, as it varies across regions and affects genders differently. This underscores the need for targeted in….
0
4
0
RT @ntvuganda: Lenacapvir is used for the treatment of HIV, but now we are exploring its role in the prevention of HIV. It has been availab….
0
9
0
RT @ntvuganda: We've had oral PrEP for some time now, but stigma has been a barrier for many people, as they fear others might think they'r….
0
5
0